Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

MedCap

534.00 SEK

-1.11 %

Less than 1K followers

MCAP

NASDAQ Stockholm

Investment

Financials

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
-1.11 %
-8.09 %
-11.88 %
+21.09 %
-11.15 %
-9.03 %
+153.08 %
+134.21 %
+5,187.13 %

MedCap operates in the investment industry and focuses on long-term equity investments in medical technology and pharmaceutical companies. The company's portfolio includes companies in sectors such as biotechnology and medical technology. The operations are primarily concentrated in Sweden, with a primary presence in the Stockholm region. MedCap was founded in 2001 and is headquartered in Stockholm.

Read more
Market cap
8.03B SEK
Turnover
5.01M SEK
Revenue
1.81B
EBIT %
15.07 %
P/E
38.14
Dividend yield-%
-
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
6/2
2026

Annual report '25

29/4
2026

Interim report Q1'26

21/7
2026

Interim report Q2'26

All
Press releases
3rd party
ShowingAll content types
Regulatory press release12/2/2025, 7:35 PM

Ledningsförändringar i MedCap AB

MedCap
Press release10/27/2025, 1:26 PM

Redeye: MedCap (Q3 review) - Healthy Q3 figures

MedCap
Regulatory press release10/24/2025, 4:30 AM

MedCap AB: Stark organisk och förvärvad tillväxt; EBITA ökade med 32%

MedCap

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release10/24/2025, 4:30 AM

MedCap AB: Strong organic and acquired growth; EBITA increased by 32%

MedCap
Regulatory press release10/15/2025, 6:30 AM

MedCap AB: Valberedning i MedCap utsedd

MedCap
Regulatory press release10/1/2025, 1:00 PM

MedCap AB: Abilia förvärvar LivAssured

MedCap
Regulatory press release10/1/2025, 1:00 PM

MedCap AB: Abilia acquires LivAssured

MedCap
Press release7/23/2025, 12:05 PM

Redeye: MedCap Q2 2025 - The rise, fall, and rise again

MedCap
Regulatory press release7/23/2025, 4:30 AM

MedCap AB: Starkt kvartal med 20 procent EBITA tillväxt samt förvärv inom Specialistläkemedel

MedCap
Regulatory press release7/23/2025, 4:30 AM

MedCap AB: Strong quarter with 20 percent EBITA growth and acquisition in Specialty Pharma

MedCap
Regulatory press release7/21/2025, 10:00 AM

MedCap AB: MedCap's Business Area Specialty Pharma Completes the Acquisition of XGX Pharma

MedCap
Regulatory press release7/21/2025, 10:00 AM

MedCap AB: MedCaps Affärsområde Specialistläkemedel fullföljer förvärvet av XGX Pharma

MedCap
Regulatory press release6/25/2025, 5:30 AM

MedCap AB: MedCap's Business Area Specialty Pharma Acquires XGX Pharma

MedCap
Regulatory press release6/25/2025, 5:30 AM

MedCap AB: MedCaps Affärsområde Specialistläkemedel förvärvar XGX Pharma

MedCap
Regulatory press release5/30/2025, 6:30 AM

Ändring av antal aktier och röster i MedCap AB

MedCap
Regulatory press release5/27/2025, 4:30 PM

MedCap AB: Återköp av aktier i MedCap 22 maj 2025 - 27 maj 2025 - återköpsprogram avslutat

MedCap
Regulatory press release5/21/2025, 5:00 PM

MedCap AB: Återköp av aktier i MedCap 15 maj 2025 - 21 maj 2025

MedCap
Regulatory press release5/14/2025, 4:45 PM

MedCap AB: Återköp av aktier i MedCap 8 maj 2025 - 14 maj 2025

MedCap
Regulatory press release5/7/2025, 3:30 PM

MedCap AB: MedCap beslutar om aktieåterköpsprogram

MedCap
Regulatory press release5/5/2025, 4:00 PM

MedCap AB: Stämmokommuniké årsstämma 5 maj 2025

MedCap
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.